Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell
-
Epazz Holdings: ZenaDrone Secures Additional Funding for Phase 1 of the US Air Force Contract SBIR
-
MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024
-
Chijet Motor Company, Inc.’s Subsidiary FAW Jilin Breaks Ground in South America with Export of 100 Senia R7 Taxis to Colombia
-
CISO GLOBAL ANNOUNCES EFFECTIVE DATE FOR REVERSE STOCK SPLIT
-
LIGA Highlights Significant Achievements in 2024 and Presents a Forecast for the Upcoming Year
-
Blüm Subsidiary Unrivaled Files Suit Against Bernard Steimann, Dan Troup, and Troup Construction for Theft
-
Global Franchise Selects Bridgeline to Provide Hosting for More than 200 Locations
-
Blade Air Mobility to Present at Upcoming Investor Conferences
-
Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia
-
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
-
Blue Rhino Renews its Partnership with the Steak Cookoff Association
-
Sprott Launches Copper Miners ETF
-
Aktia Bank Plc: Managers’ Transactions – Anssi Huhta
-
Aktia Bank Plc: Managers’ Transactions – Outi Henriksson
-
Aktia Bank Plc: Managers’ Transactions – Juha Hammarén
-
BEZTAK AWARDED 44 KINGSLEY EXCELLENCE AWARDS, WITH ALL SEASONS BIRMINGHAM IN #1 PLACEMENT
-
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 13, 2024
-
TRxADE Health, Inc. Announces Special Cash Dividend
-
Unlimited Builds Out C-Suite, Appointing Hedge Fund Veteran John K. E. Morris as Chief Commercial Officer
-
Dimensional Fund Advisors Ltd. : Form 8.3 - WINCANTON PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - Urban Logistics REIT plc - Ordinary Shares
-
Alumis Announces Upsized $259M Series C Financing to Advance Clinical-stage Pipeline of Oral Therapies Designed to Address Immune Dysfunction
-
Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences
-
Odyssey Trust Company Announces Collaboration with Generation IACP Inc.
-
Krispy Kreme® Canada expands with the opening of its first Winnipeg location
-
Infinidat Is Recognized in the 2024 Gartner® Peer Insights™ Voice of the Customer for Primary Storage as North America Customers’ Choice for the Second Consecutive Year
-
Asia Broadband Signs Definitive Acquisition Agreement for High-Grade Gold Property in Jalisco Mexico
-
Bearing AI Launches EU ETS Compliance Tool
-
Araris Biotech AG to Present Data on Antibody-Drug Conjugate Candidates at American Association for Cancer Research (AACR) Annual Meeting 2024
-
Werewolf Therapeutics to Present at the 2024 Leerink Partners Global Biopharma Conference
-
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
-
INNOVATE Corp. Announces Rights Offering Pricing
-
BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares
-
Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of Fibromyalgia
-
Par Pacific Management to Participate in Investor Conferences
-
REE Announces Closing of Public Offering of Ordinary Shares
-
Infinera Announces Availability of Next Generation Multi-haul Optical Line System Functionality for Industry-leading GX Series Platform
-
CPS Technologies and Triton Systems Announce New Licensing Agreement
-
Apnimed to Participate in the Upcoming Leerink Partners Global Biopharma Conference
-
Greenridge Exploration Engages Dahrouge Consulting
-
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
-
Auron Announces Poster Presentations at 2024 AACR Annual Meeting
-
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
-
Vaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and Director
-
M&C Communications marks its 15th anniversary with the addition of two new team members
-
Cidara Therapeutics to Present Preclincal Data on Multiple Novel Drug-Fc Conjugate Candidates at American Association dor Cancer Research (AACR) Annual Meeting 2024
-
Gabelli Funds to Host 15th Annual Specialty Chemicals Symposium Thursday, March 14, 2024
-
Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers
